We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AbbVie Drops Case Blocking EMA Transparency Initiative, Intermune Continues Fight
AbbVie Drops Case Blocking EMA Transparency Initiative, Intermune Continues Fight
AbbVie has dropped two lawsuits against the EMA over the agency’s plans to disclose clinical trial data for its rheumatoid arthritis drug Humira (adalimumab), clearing a major hurdle for the EMA’s transparency initiative.